These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7840596)

  • 1. Azole resistance in oropharyngeal Candida albicans strains isolated from patients infected with human immunodeficiency virus.
    He X; Tiballi RN; Zarins LT; Bradley SF; Sangeorzan JA; Kauffman CA
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2495-7. PubMed ID: 7840596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of itraconazole against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus.
    Barchiesi F; Colombo AL; McGough DA; Fothergill AW; Rinaldi MG
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1530-3. PubMed ID: 7979284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.
    Martinez M; López-Ribot JL; Kirkpatrick WR; Coco BJ; Bachmann SP; Patterson TF
    J Clin Microbiol; 2002 Sep; 40(9):3135-9. PubMed ID: 12202543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis.
    Cartledge JD; Midgley J; Gazzard BG
    AIDS; 1997 Dec; 11(15):1839-44. PubMed ID: 9412702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection.
    Ruhnke M; Eigler A; Tennagen I; Geiseler B; Engelmann E; Trautmann M
    J Clin Microbiol; 1994 Sep; 32(9):2092-8. PubMed ID: 7814530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the fungitest kit by using strains from human immunodeficiency virus-infected patients: study of azole drug susceptibility.
    Witthuhn F; Toubas D; Béguinot I; Aubert D; Rouger C; Remy G; Pinon JM
    J Clin Microbiol; 1999 Mar; 37(3):864-6. PubMed ID: 9986878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fluconazole-resistant Candida species from HIV infected patients with recurrent Candida stomatitis: cross resistance to itraconazole and ketoconazole].
    Metzger S; Hofmann H
    Mycoses; 1997; 40 Suppl 1():56-63. PubMed ID: 9417515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azole-resistant Candida albicans: report of two cases of resistance to fluconazole and review.
    White A; Goetz MB
    Clin Infect Dis; 1994 Oct; 19(4):687-92. PubMed ID: 7803633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of resistance of Candida albicans to clotrimazole in human immunodeficiency virus-infected children: in vitro and clinical correlations.
    Pelletier R; Peter J; Antin C; Gonzalez C; Wood L; Walsh TJ
    J Clin Microbiol; 2000 Apr; 38(4):1563-8. PubMed ID: 10747144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does long-term itraconazole prophylaxis result in in vitro azole resistance in mucosal Candida albicans isolates from persons with advanced human immunodeficiency virus infection? The National Institute of Allergy and Infectious Diseases Mycoses study group.
    Goldman M; Cloud GA; Smedema M; LeMonte A; Connolly P; McKinsey DS; Kauffman CA; Moskovitz B; Wheat LJ
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1585-7. PubMed ID: 10817713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to Candida albicans.
    Laguna F; Rodríguez-Tudela JL; Martínez-Súarez JV; Polo R; Valencia E; Díaz-Guerra TM; Dronda F; Pulido F
    Clin Infect Dis; 1997 Feb; 24(2):124-30. PubMed ID: 9114134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable antifungal susceptibility of wild-type Candida albicans phenotypes from neutropenic hosts.
    Velegraki A; Papalambrou D; Soremi S; Legakis NJ
    Eur J Clin Microbiol Infect Dis; 1996 Nov; 15(11):854-60. PubMed ID: 8997556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility to itraconazole and fluconazole of switch phenotypes of Candida albicans serotypes A and B, isolated from immunocompromised hosts.
    Velegraki A
    J Med Vet Mycol; 1995; 33(1):83-5. PubMed ID: 7650586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
    Sanglard D; Kuchler K; Ischer F; Pagani JL; Monod M; Bille J
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative evaluation of Etest and broth microdilution methods for fluconazole and itraconazole susceptibility testing of Candida spp.
    Martín-Mazuelos E; Gutiérrez MJ; Aller AI; Bernal S; Martínez MA; Montero O; Quindós G
    J Antimicrob Chemother; 1999 Apr; 43(4):477-81. PubMed ID: 10350375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of a new antifungal triazole, D0870, against Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus.
    Barchiesi F; Colombo AL; McGough DA; Fothergill AW; Rinaldi MG
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2553-6. PubMed ID: 7872746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antifungal activity of BMS-207147 and itraconazole against yeast strains that are non-susceptible to fluconazole.
    Fung-Tomc JC; White TC; Minassian B; Huczko E; Bonner DP
    Diagn Microbiol Infect Dis; 1999 Oct; 35(2):163-7. PubMed ID: 10579098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of in vitro activity of itraconazole and imidazole antifungal agents against Candida albicans with decreased susceptibility to fluconazole from Spain.
    Martinez-Suarez JV; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1512-6. PubMed ID: 7492095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of rilopirox against fluconazole-susceptible and fluconazole-resistant Candida isolates from patients with HIV infection.
    Nenoff P; Taneva E; Pfeil B; Oswald U; Haustein UF
    Mycoses; 1999 Apr; 42(1-2):55-60. PubMed ID: 10394849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluconazole and itraconazole susceptibilities of Candida spp. isolated from oropharyngeal specimens and blood cultures of paediatric haematology/oncology patients.
    Kennedy HF; Shankland GS; Bagg J; Chalmers EA; Gibson BE; Williams CL
    Mycoses; 2006 Nov; 49(6):457-62. PubMed ID: 17022761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.